stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / RDNT

RadNet, Inc. (RDNT)

Healthcare · Diagnostics & Research · NasdaqGM

Price
$58.13
Market Cap
$4.57B
P/E Ratio
0.00
EPS
$-0.17
Sector
Healthcare
52-Week High
$85.84
52-Week Low
$50.76
Dividend Yield

RadNet, Inc. revenue & earnings — last 10 fiscal years

Metric2016201720182019202020212022202320242025
Revenue$884.53M$922.19M$975.15M$1.15B$1.07B$1.32B$1.43B$1.62B$1.83B$2.04B
Gross profit$108.73M$119.81M$107.60M$154.49M
Net income$7.23M$53,000$32.24M$14.76M$-14.84M$24.73M$10.65M$3.04M$2.79M$-18.65M
Net margin0.8%0.0%3.3%1.3%-1.4%1.9%0.7%0.2%0.2%-0.9%

Source: RadNet, Inc. SEC filings (10-K). 17 years of history available in the interactive view.

Explore 17 years of RadNet, Inc. financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track RDNT in your portfolio →

About RadNet, Inc.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RadNet, Inc. — frequently asked questions

What is RadNet, Inc.'s revenue?

RadNet, Inc. (RDNT) reported revenue of $2.04B for fiscal year 2025, up 11.5% from the prior year, according to its SEC filings.

Is RadNet, Inc. profitable?

No — RDNT reported a net loss of $-18.65M in fiscal 2025.

What is RDNT's P/E ratio?

RadNet, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.

How fast is RadNet, Inc. growing?

RDNT's revenue grew at roughly 13.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

Where does this data come from?

All figures are computed from RadNet, Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 500+ companies → · Screen them by fundamentals →